Sign In
Buy DNLI
$19.66
+0.310 (+1.60%)
At Close: Jun 03, 2026
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cro
F-star Therapeutics: New Biologics Platform For Immunotherapy
11:00am, Thursday, 21'st Jan 2021
F-star Therapeutics: New Biologics Platform For Immunotherapy
Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors
08:30am, Monday, 11'th Jan 2021
SOUTH SAN FRANCISCO, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cro
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cro
Why MongoDB, Blink Charging, Ampio Pharmaceuticals, and Denali Therapeutics Stocks Tanked Today
03:33pm, Wednesday, 23'rd Dec 2020
2020 is almost over. Maybe it's time to cash in -- and cash out?
5 Medical Outperformers That Might Lose Steam in 2021
10:32am, Tuesday, 22'nd Dec 2020
Here we discuss some biotech stocks, which are up this year so far but might not be good additions to your portfolio.
7 Biotech Stocks To Buy Beyond Covid Vaccine Plays
01:37pm, Monday, 14'th Dec 2020
It's a relief to know Covid-19 vaccines are on the way. But there are plenty of other great biotechs that have been overlooked in the market frenzy.
3 Best Biotech Stocks to Buy in November
09:36am, Wednesday, 18'th Nov 2020
While most investors are watching the companies working to end the COVID-19 crisis, take a moment to consider three that are continuing the fight against an even more stubborn disease.
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cro
Denali Therapeutics (DNLI) Investor Presentation - Slideshow
01:51pm, Monday, 14'th Sep 2020
The following slide deck was published by Denali Therapeutics Inc. in conjunction with this event..
Regenerative Medicine: Does BioMarin Complete Response Letter Change The Outlook?
01:24pm, Tuesday, 25'th Aug 2020
Over a dozen regenerative medicine drugs have been launched, generating revenues approaching $4 billion in 2019.
Denali Is Flush With Cash After Partnership With Biogen
07:28am, Wednesday, 19'th Aug 2020
Denali Therapeutics struck a deal with Biogen for its LRRK2 inhibitor program earlier this month that resulted in the company receiving over $1 billion in cash.
Loss-Making Denali Therapeutics Inc. (NASDAQ:DNLI) Set To Breakeven
03:37pm, Tuesday, 18'th Aug 2020
Denali Therapeutics Inc. (NASDAQ:DNLI) is possibly approaching a major achievement in its business, so we would like...
Genomic Medicine: Summer 2020 Update
09:36am, Thursday, 13'th Aug 2020
FDA approvals, new guidance statements, and RMAT requests all show the pace of genomics is accelerating.
Week In Review: BioKangtai Acquires China Rights To AstraZeneca's COVID-19 Vaccine
08:02pm, Sunday, 09'th Aug 2020
BioKangtai, a Guangdong vaccine company, in-licensed rights to develop, manufacture and market AstraZeneca's COVID-19 vaccine in China.
